Home/Filings/4/0000950170-24-064607
4//SEC Filing

Bruno Julianne 4

Accession 0000950170-24-064607

CIK 0001674416other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 4:15 PM ET

Size

5.3 KB

Accession

0000950170-24-064607

Insider Transaction Report

Form 4
Period: 2024-05-23
Bruno Julianne
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2024-05-23+20,00020,000 total
    Common Shares (20,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
  • [F2]This restricted stock unit award was granted on May 23, 2024 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 23, 2026.

Documents

1 file

Issuer

CRISPR Therapeutics AG

CIK 0001674416

Entity typeother

Related Parties

1
  • filerCIK 0002019645

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:15 PM ET
Size
5.3 KB